Large-scale testing (Phase 3)UnknownNCT03709316
What this trial is testing
ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Who this might be right for
Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 384